Treatment of Life-Threatening Infantile Hemangiomas with Vincristine

Autor:	Jose Pardo Masferrer, Jaime Perez Payarols, Cristina Gomez Bellvert
Rok vydání:	1995
Předmět:	medicine.medical_specialty Vincristine Medical treatment business.industry Mortality rate General Medicine medicine.disease Surgery Hemangioendothelioma Hemangioma Medicine Supraclavicular region business Benign Hemangioendothelioma medicine.drug
Zdroj:	New England Journal of Medicine. 333:69-69
ISSN:	1533-4406 0028-4793
Popis:	To the Editor: We describe two cases of corticosteroid-resistant, life-endangering hemangioma treated with vincristine: a benign hemangioendothelioma in a patient with Kasabach-Merritt syndrome and a liver hemangioendothelioma. Mortality rates among patients with these kinds of hemangioma can be as high as 40 percent and may be more than 50 percent if poor prognostic factors are present.1,2 Corticosteroids are the medical treatment of choice, except for resistant cases,3 which are not infrequent. The first patient was a nine-month-old baby who presented with a tumor 10 cm in diameter in the left supraclavicular region and a platelet count of 7400 per . . .
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2647979b298dc475ff0b6a164947cf9a https://doi.org/10.1056/nejm199507063330120 Zobrazit plný text záznamu